(Q44829771)

6 December 2017

title

Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders (English)

1 reference

6 December 2017

Mark Zimmerman

1

1 reference

6 December 2017

Thomas Sheeran

series ordinal

2

1 reference

6 December 2017

Iwona Chelminski

series ordinal

3

1 reference

6 December 2017

Diane Young

series ordinal

4

1 reference

6 December 2017

publication date

1 April 2004

1 reference

Journal of Substance Abuse Treatment

6 December 2017

published in

1 reference

6 December 2017

volume

26

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

181-188

1 reference

Screening for concomitant alcohol abuse in schizophrenia: clinical significance of the Munich Alcoholism Test and laboratory tests

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Methods to improve diagnostic accuracy in a community mental health setting

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

The RAFFT as a screening tool for adult substance use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Alcohol screening questionnaires in women: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

PTSD Substance abuse comorbidity and treatment utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Low Dose Desipramine Treatment of Cocaine-Related Panic Attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Convergent and discriminant validation by the multitrait-multimethod matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

A brief screening instrument for problem drinking in the emergency room: the RAPS4. Rapid Alcohol Problems Screen.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Screening for PTSD in a substance abuse sample: psychometric properties of a modified version of the PTSD Symptom Scale Self-Report. Posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

HIV seroprevalence among people with severe mental illness in the United States: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

The effectiveness of routine screening questions in the detection of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Screening for substance abuse and psychiatric disorders among women patients in a VA Health Care System

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Patients with alcohol problems in the emergency department, part 1: improving detection. SAEM Substance Abuse Task Force. Society for Academic Emergency Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Preventive care in the emergency department: screening and brief intervention for alcohol problems in the emergency department: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Automated telephone-administered substance abuse screening for adults in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Efficiency and validity of commonly used substance abuse screening instruments in public psychiatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Screening for alcohol problems in primary care: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Alcoholism, depression, and life events

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Screening and diagnosis of anxiety and mood disorders in substance abuse patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Effects of major depression on remission and relapse of substance dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Screening for psychiatric comorbidity among female alcoholics: the use of a questionnaire (SCL-90) among women early in their treatment programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Development of a computerized screening system to identify substance abuse in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Imipramine as Treatment for Depression in Addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

The relationship between syndrome and personality disorder in DSM-III: experience with 2,462 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

HIV risk factors in dually diagnosed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Psychiatric hospital outcomes of dual diagnosis patients under managed care.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

A placebo-controlled trial of buspirone in anxious inpatient alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Reliability and validity of screening instruments for drug and alcohol abuse in adults seeking evaluation for attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

DSM-III disorders in a large sample of psychiatric patients: frequency and specificity of diagnoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Maximizing diagnostic information from the dexamethasone suppression test. An approach to criterion selection using receiver operating characteristic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Prognostic effect of the variable course of alcoholism on the 10-year course of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Medication noncompliance and substance abuse among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Outcomes of Co‐Morbid Alcoholic Men: A 1‐Year Follow‐Up

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Co-occurring severe mental illness and substance use disorders: a review of recent research

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Psychopathology and substance abuse as predictors of program completion in a therapeutic community for drug abusers: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

The prevalence of psychiatric disorders in patients with alcohol and other drug problems

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Psychopathology as a predictor of treatment outcome in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Detecting depressive disorders in drug abusers: a comparison of screening instruments

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Placebo-controlled study of sertraline in depressed recently abstinent alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Diagnosis of Nonpsychotic Patients in Community Clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Comorbidity in a clinical sample of substance abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Psychometric properties of the Drug Abuse Screening Test in a psychiatric patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Violence by People Discharged From Acute Psychiatric Inpatient Facilities and by Others in the Same Neighborhoods

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

A nationwide representative sample of treatment-seeking alcoholics: a study of psychiatric comorbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Substance dependence posttraumatic stress disorder therapy. An integrated cognitive-behavioral approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Diagnosing major depression in cocaine abusers: the use of depression rating scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Psychiatric diagnosis in clinical practice: is comorbidity being missed?

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Cognitive-behavioral treatment for depression in alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Methodological considerations in the assessment of depression in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Psychiatric comorbidity, health status, and functional impairment associated with alcohol abuse and dependence in primary care patients: findings of the PRIME MD-1000 study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

Comorbidity of schizophrenia and substance abuse: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900207-1

7 January 2021

10.1016/S0740-5472(03)00207-1

Identifiers

DOI

1 reference

6 December 2017

1 reference